The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - MSD Oncology

Human papillomavirus infection in metastatic lung adenocarcinoma is associated with better outcomes with immune checkpoint inhibitor treatment.
 
Luis Leonardo Rojas Puentes
No Relationships to Disclose
 
Alejandro Ruiz-Patiño
No Relationships to Disclose
 
Diana Carolina Mayorga Gonzalez
No Relationships to Disclose
 
July Katherine Rodríguez
No Relationships to Disclose
 
Jenny Mireya Ávila Coy
No Relationships to Disclose
 
Melissa Andrea Bravo Espinosa
No Relationships to Disclose
 
Zyanya Lucía Zatarain-Barron
No Relationships to Disclose
 
Oscar Arrieta
No Relationships to Disclose
 
Feliciano Barron Barron
No Relationships to Disclose
 
Hernan Carranza
No Relationships to Disclose
 
Jorge Miguel Otero
No Relationships to Disclose
 
Carlos Alberto Vargas
No Relationships to Disclose
 
Pilar Archila
No Relationships to Disclose
 
Diana Carolina Sotelo Rodríguez
No Relationships to Disclose
 
Claudio Marcelo Martin
No Relationships to Disclose
 
Luis Eduardo Pino
No Relationships to Disclose
 
Christian Diego Rolfo
Consulting or Advisory Role - Mylan
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Guardant Health; MSD; Novartis
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Biomark (Inst); OncoDNA
 
Rafael Rosell
No Relationships to Disclose
 
Andres Felipe Cardona Zorrilla
Honoraria - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Celldex; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Foundation for Clinical and Applied Cancer Research (FICMAC); Foundation Medicine; Merck Sharp & Dohme; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Foundation for Clinical and Applied Cancer Research (FICMAC); Foundation Medicine; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Foundation Medicine; Merck Sharp & Dohme; Roche
 
Gonzalo Recondo
No Relationships to Disclose